VERICEL CORPORATION Financing Cash Flow
VERICEL CORPORATION (VCEL) reported Financing Cash Flow of -$287.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-30
- VERICEL CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.69M, a 64.05% increase year-over-year.
- VERICEL CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$2.98M, a 193.15% decline year-over-year.
- VERICEL CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.06M, a 85.02% decline year-over-year.
- VERICEL CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.17M, a 78.89% decline year-over-year.
- VERICEL CORPORATION net cash provided by (used in) financing activities for fiscal 2025 was $7.07M, a 62.89% decline from fiscal 2024.
- VERICEL CORPORATION net cash provided by (used in) financing activities for fiscal 2024 was $19.05M, a 426.64% increase from fiscal 2023.
- VERICEL CORPORATION net cash provided by (used in) financing activities for fiscal 2023 was $3.62M, a 246.22% increase from fiscal 2022.
- VERICEL CORPORATION net cash provided by (used in) financing activities for fiscal 2022 was $1.04M, a 88.61% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 267 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$287.00K 10-Q · filed 2026-07-30 | $778.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.94M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | -$2.98M 10-Q · filed 2026-05-07 | -$1.91M derived: sum of 2 quarters · filed 2026-05-07 | -$748.00K derived: sum of 3 quarters · filed 2026-05-07 | $893.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.23M derived: sum of 2 quarters · filed 2026-02-26 | $3.87M derived: sum of 3 quarters · filed 2026-07-30 | $7.07M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.81M derived: sum of 2 quarters · filed 2026-07-30 | $6.00M 10-Q · filed 2025-11-06 | $13.11M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.84M 10-Q · filed 2026-07-30 | $11.95M derived: sum of 3 quarters · filed 2026-07-30 | $17.47M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $3.20M 10-Q · filed 2026-05-07 | $10.31M derived: sum of 2 quarters · filed 2026-05-07 | $15.83M derived: sum of 3 quarters · filed 2026-05-07 | $20.13M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.63M derived: sum of 2 quarters · filed 2026-02-26 | $16.93M derived: sum of 3 quarters · filed 2026-02-26 | $19.05M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.82M derived: sum of 2 quarters · filed 2025-11-06 | $11.95M 10-Q · filed 2025-11-06 | $13.25M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $6.42M 10-Q · filed 2025-07-31 | $7.73M derived: sum of 3 quarters · filed 2026-02-26 | $8.74M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $2.13M 10-Q · filed 2025-05-08 | $3.43M derived: sum of 2 quarters · filed 2026-02-26 | $4.44M derived: sum of 3 quarters · filed 2026-02-26 | $5.64M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.32M derived: sum of 2 quarters · filed 2026-02-26 | $3.51M derived: sum of 3 quarters · filed 2026-02-26 | $3.62M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.20M derived: sum of 2 quarters · filed 2024-11-07 | $2.31M 10-Q · filed 2024-11-07 | $2.92M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.30M 10-Q · filed 2024-08-01 | $1.91M derived: sum of 3 quarters · filed 2025-02-27 | $1.59M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $107.00K 10-Q · filed 2024-05-08 | $712.00K derived: sum of 2 quarters · filed 2025-02-27 | $400.00K derived: sum of 3 quarters · filed 2025-02-27 | $649.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $293.00K derived: sum of 2 quarters · filed 2025-02-27 | $542.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.04M 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$312.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$63.00K derived: sum of 2 quarters · filed 2023-11-08 | $440.00K 10-Q · filed 2023-11-08 | $1.78M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $752.00K 10-Q · filed 2023-08-02 | $2.09M derived: sum of 3 quarters · filed 2024-02-29 | $3.88M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $503.00K 10-Q · filed 2023-05-10 | $1.84M derived: sum of 2 quarters · filed 2024-02-29 | $3.63M derived: sum of 3 quarters · filed 2024-02-29 | $7.41M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.13M derived: sum of 2 quarters · filed 2024-02-29 | $6.91M derived: sum of 3 quarters · filed 2024-02-29 | $9.17M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.57M derived: sum of 2 quarters · filed 2022-11-09 | $7.83M 10-Q · filed 2022-11-09 | $12.28M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $6.04M 10-Q · filed 2022-08-03 | $10.50M derived: sum of 3 quarters · filed 2023-02-23 | $11.29M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $2.26M 10-Q · filed 2022-05-04 | $6.72M derived: sum of 2 quarters · filed 2023-02-23 | $7.51M derived: sum of 3 quarters · filed 2023-02-23 | $8.40M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.25M derived: sum of 2 quarters · filed 2023-02-23 | $6.13M derived: sum of 3 quarters · filed 2023-02-23 | $6.44M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $791.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.68M derived: sum of 2 quarters · filed 2021-11-09 | $1.99M 10-Q · filed 2021-11-09 | $3.51M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $890.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.20M 10-Q · filed 2021-08-04 | $2.72M derived: sum of 3 quarters · filed 2022-02-24 | $4.41M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $306.00K 10-Q · filed 2021-05-05 | $1.83M derived: sum of 2 quarters · filed 2022-02-24 | $3.52M derived: sum of 3 quarters · filed 2022-02-24 | $4.58M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.21M derived: sum of 2 quarters · filed 2022-02-24 | $4.28M derived: sum of 3 quarters · filed 2022-02-24 | $5.26M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.75M derived: sum of 2 quarters · filed 2020-11-05 | $3.73M 10-Q · filed 2020-11-05 | -$13.44M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.05M 10-Q · filed 2020-08-05 | -$15.12M derived: sum of 3 quarters · filed 2021-02-24 | -$13.21M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $982.00K 10-Q · filed 2020-05-11 | -$16.19M derived: sum of 2 quarters · filed 2021-02-24 | -$14.28M derived: sum of 3 quarters · filed 2021-02-24 | $57.15M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | -$17.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$15.26M derived: sum of 2 quarters · filed 2021-02-24 | $56.17M derived: sum of 3 quarters · filed 2021-02-24 | $58.86M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $73.34M derived: sum of 2 quarters · filed 2019-11-05 | $76.03M 10-Q · filed 2019-11-05 | $87.31M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $71.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $74.12M 10-Q · filed 2019-08-06 | $85.40M derived: sum of 3 quarters · filed 2020-02-25 | $92.59M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $2.69M 10-Q · filed 2019-05-07 | $13.97M derived: sum of 2 quarters · filed 2020-02-25 | $21.16M derived: sum of 3 quarters · filed 2020-02-25 | $21.21M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $11.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $18.46M derived: sum of 2 quarters · filed 2020-02-25 | $18.52M derived: sum of 3 quarters · filed 2020-02-25 | $18.58M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $7.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $7.24M derived: sum of 2 quarters · filed 2018-11-06 | $7.30M 10-Q · filed 2018-11-06 | $30.80M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $112.00K 10-Q · filed 2018-08-06 | $23.62M derived: sum of 3 quarters · filed 2019-02-26 | $27.18M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | $61.00K 10-Q · filed 2018-05-08 | $23.57M derived: sum of 2 quarters · filed 2019-02-26 | $27.13M derived: sum of 3 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $23.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $27.07M derived: sum of 2 quarters · filed 2019-02-26 | $29.70M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $6.20M 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $2.64M 10-Q · filed 2017-08-09 | ||||
| 2015-12-31 | -$24.00K 10-K · filed 2018-03-05 | ||||
| 2011-06-30 | -$107.00K 10-Q · filed 2011-08-15 | $237.88M 10-Q · filed 2011-08-15 | |||
| 2010-06-30 | $12.32M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |